We are live on ! Find out more
Mackenzie Financial

Mackenzie Financial Portfolio holdings

AUM $83.3B
1-Year Est. Return 31.19%
This Fund
S&P 500
This Quarter Est. Return
+11.39%
1 Year Est. Return
+31.19%
3 Year Est. Return
+75.49%
5 Year Est. Return
+99.03%
10 Year Est. Return
+295.58%
AUM
$66.3B
AUM Growth
+$6.83B
Cap. Flow
-$878M
Cap. Flow %
-1.32%
Top 10 Hldgs %
22.69%
Holding
1,623
New
157
Increased
524
Reduced
643
Closed
131

Top Buys

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$196M
2
WCN
Waste Connections
WCN
+$176M
3
MSFT icon
Microsoft
MSFT
+$173M
4
ROP icon
Roper Technologies
ROP
+$145M
5
CPRT icon
Copart
CPRT
+$129M

Top Sells

Rank Stock Value
1
APH icon
Amphenol
APH
+$295M
2
TMO icon
Thermo Fisher Scientific
TMO
+$292M
3
TRI icon
Thomson Reuters
TRI
+$218M
4
KEYS icon
Keysight
KEYS
+$164M
5
ON icon
ON Semiconductor
ON
+$112M

Sector Composition

Rank Sector Weight
1 Financials 21.45%
2 Technology 19.78%
3 Industrials 13.23%
4 Healthcare 8.92%
5 Energy 7.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QUAD icon
1426
Quad
QUAD
$536M
$71.9K ﹤0.01%
+13,259
New +$64.7K
SFIX
1427
Stitch Fix
SFIX
$536M
$70.5K ﹤0.01%
+19,740
New +$69.7K
SB icon
1428
Safe Bulkers
SB
$795M
$69.6K ﹤0.01%
17,716
PAYO icon
1429
Payoneer
PAYO
$2.42B
$69.6K ﹤0.01%
13,355
COMP icon
1430
Compass
COMP
$8.51B
$63.6K ﹤0.01%
16,915
PGRE
1431
DELISTED
Paramount Group
PGRE
$63.3K ﹤0.01%
12,251
PRTS icon
1432
CarParts.com
PRTS
$43.7M
$63.2K ﹤0.01%
1,999
+973
+95% +$32.9K
EEX
1433
DELISTED
Emerald Holding
EEX
$62.8K ﹤0.01%
10,501
-2,609
-20% -$13.7K
XERS icon
1434
Xeris Biopharma Holdings
XERS
$1.39B
$61K ﹤0.01%
25,978
BCOV
1435
DELISTED
Brightcove, Inc.
BCOV
$59.6K ﹤0.01%
22,993
+8,186
+55% +$22K
CDE icon
1436
Coeur Mining
CDE
$15.4B
$59.4K ﹤0.01%
18,217
MNKD icon
1437
MannKind Corp
MNKD
$1.21B
$59.3K ﹤0.01%
16,302
DHC
1438
Diversified Healthcare Trust
DHC
$2.15B
$58.2K ﹤0.01%
15,549
ETWO
1439
DELISTED
E2open Parent Holdings
ETWO
$57.2K ﹤0.01%
13,022
ORGO icon
1440
Organogenesis Holdings
ORGO
$305M
$56.4K ﹤0.01%
13,791
-1,543
-10% -$4.32K
ARC
1441
DELISTED
ARC Document Solutions, Inc.
ARC
$56.1K ﹤0.01%
17,097
+1,783
+12% +$5.23K
VISN
1442
Vistance Networks Inc
VISN
$2.65B
$55K ﹤0.01%
19,514
+6,949
+55% +$15K
NGM
1443
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$54.1K ﹤0.01%
62,964
+18,084
+40% +$15.9K
NAT icon
1444
Nordic American Tanker
NAT
$1.38B
$52.1K ﹤0.01%
12,394
GERN icon
1445
Geron
GERN
$828M
$50.9K ﹤0.01%
24,142
RIGL icon
1446
Rigel Pharmaceuticals
RIGL
$681M
$50.6K ﹤0.01%
3,488
+176
+5% +$1.8K
LAZR
1447
DELISTED
Luminar Technologies
LAZR
$49.2K ﹤0.01%
974
-674
-41% -$33.5K
UPLD icon
1448
Upland Software
UPLD
$12.8M
$47.6K ﹤0.01%
1,126
-82
-7% -$3.54K
AVAH icon
1449
Aveanna Healthcare
AVAH
$2.04B
$46.8K ﹤0.01%
17,457
-13,686
-44% -$26.1K
VNDA icon
1450
Vanda Pharmaceuticals
VNDA
$307M
$46K ﹤0.01%
+10,906
New +$44K

Similar funds

Mackenzie Financial's Q4 2023 Portfolio in Review

As of Q4 2023, Mackenzie Financial held 1,623 positions worth $66.3B, up 11% from $59.5B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Mackenzie Financial's Q4 2023 filing shows 157 new, 524 increased, 643 reduced and 131 closed positions. Its largest new stake was Transmedics: 453,615 shares worth $35.8M. The largest sale was Amphenol, an estimated $295M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 20% a quarter earlier, followed by Technology and Industrials.

  • Mackenzie Financial's largest Q4 2023 buy was Transmedics: 453,615 shares worth $35.8M.
  • Mackenzie Financial added most to PepsiCo in Q4 2023, an estimated $196M increase.
  • Mackenzie Financial's biggest Q4 2023 reduction was Amphenol, cutting an estimated $295M.
  • Mackenzie Financial fully exited Carter's in Q4 2023, selling an estimated $24.9M.
  • Mackenzie Financial's ten largest holdings make up 23% of its $66.3B portfolio in Q4 2023.
  • Mackenzie Financial opened 157 new positions and closed 131 in Q4 2023.
  • Mackenzie Financial's portfolio value rose 11% quarter-over-quarter to $66.3B.

Based on Mackenzie Financial's 13F filing for Q4 2023, filed 30 Jan 2024.